EGFR and non-small cell lung carcinoma: It has been shown in clinical studies that EGFR is overexpressed in 40–80% of non-small-cell lung carcinomas (NSCLCs) (Bunn and Franklin, 2002), and in preneoplastic lesions (Flanklin et al, 2002).